These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23095131)

  • 21. Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells.
    Zaza G; Masola V; Granata S; Bellin G; Dalla Gassa A; Onisto M; Gambaro G; Lupo A
    J Nephrol; 2015 Aug; 28(4):431-40. PubMed ID: 26054821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulodexide ameliorates early but not late kidney disease in models of radiation nephropathy and diabetic nephropathy.
    Rossini M; Naito T; Yang H; Freeman M; Donnert E; Ma LJ; Dunn SR; Sharma K; Fogo AB
    Nephrol Dial Transplant; 2010 Jun; 25(6):1803-10. PubMed ID: 20061322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis.
    Ritchie JP; Ramani VC; Ren Y; Naggi A; Torri G; Casu B; Penco S; Pisano C; Carminati P; Tortoreto M; Zunino F; Vlodavsky I; Sanderson RD; Yang Y
    Clin Cancer Res; 2011 Mar; 17(6):1382-93. PubMed ID: 21257720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy.
    Lu Q; Ji XJ; Zhou YX; Yao XQ; Liu YQ; Zhang F; Yin XX
    Pharmacol Res; 2015 Sep; 99():237-47. PubMed ID: 26151815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of sulodexide on albuminuria, NAG excretion and glomerular filtration response to dopamine in diabetic patients.
    Sulikowska B; Olejniczak H; Muszyńska M; Odrowaz-Sypniewska G; Gaddi A; Savini C; Cicero AF; Laghi L; Manitius J
    Am J Nephrol; 2006; 26(6):621-8. PubMed ID: 17191008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy.
    Wijnhoven TJ; van den Hoven MJ; Ding H; van Kuppevelt TH; van der Vlag J; Berden JH; Prinz RA; Lewis EJ; Schwartz M; Xu X
    Diabetologia; 2008 Feb; 51(2):372-82. PubMed ID: 18058084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sulodexide improves renal function through reduction of vascular endothelial growth factor in type 2 diabetic rats.
    Cha JJ; Kang YS; Hyun YY; Han SY; Jee YH; Han KH; Han JY; Cha DR
    Life Sci; 2013 Jun; 92(23):1118-24. PubMed ID: 23643633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Danggui-Shaoyao-San-Containing Serum on the Renal Tubular Epithelial-Mesenchymal Transition of Diabetic Nephropathy.
    Xiaobing L; Chunling N; Wenyu C; Yan C; Zhenzhen L
    Curr Pharm Biotechnol; 2020; 21(12):1204-1212. PubMed ID: 32297575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy.
    Mou X; Zhou DY; Zhou D; Liu K; Chen LJ; Liu WH
    Phytomedicine; 2020 Apr; 69():153192. PubMed ID: 32200292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zinc Attenuates Tubulointerstitial Fibrosis in Diabetic Nephropathy Via Inhibition of HIF Through PI-3K Signaling.
    Zhang X; Liang D; Fan J; Lian X; Zhao Y; Wang X; Chi ZH; Zhang P
    Biol Trace Elem Res; 2016 Oct; 173(2):372-83. PubMed ID: 26956696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of heparanase-driven inflammatory cascade in pathogenesis of diabetic nephropathy.
    Goldberg R; Rubinstein AM; Gil N; Hermano E; Li JP; van der Vlag J; Atzmon R; Meirovitz A; Elkin M
    Diabetes; 2014 Dec; 63(12):4302-13. PubMed ID: 25008182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urotensin II Induces ER Stress and EMT and Increase Extracellular Matrix Production in Renal Tubular Epithelial Cell in Early Diabetic Mice.
    Pang XX; Bai Q; Wu F; Chen GJ; Zhang AH; Tang CS
    Kidney Blood Press Res; 2016; 41(4):434-49. PubMed ID: 27467277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
    Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
    Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition.
    Masola V; Granata S; Bellin G; Gambaro G; Onisto M; Rugiu C; Lupo A; Zaza G
    Nephrol Dial Transplant; 2017 Jul; 32(7):1145-1154. PubMed ID: 28064160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of human heparanase in the pathogenesis of diabetic nephropathy.
    Katz A; Van-Dijk DJ; Aingorn H; Erman A; Davies M; Darmon D; Hurvitz H; Vlodavsky I
    Isr Med Assoc J; 2002 Nov; 4(11):996-1002. PubMed ID: 12489489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of echinacoside on kidney fibrosis by inhibition of TGF-β1/Smads signaling pathway in the db/db mice model of diabetic nephropathy.
    Tang F; Hao Y; Zhang X; Qin J
    Drug Des Devel Ther; 2017; 11():2813-2826. PubMed ID: 29033543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A trial of the use of the low-molecular heparin sulodexide in the therapy of diabetic nephropathy].
    Zalevskaia AG; Astamirova KhS; Karpova IA; Popova SG
    Ter Arkh; 1998; 70(3):71-4. PubMed ID: 9575594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulodexide therapy for the treatment of diabetic nephropathy, a meta-analysis and literature review.
    Li R; Xing J; Mu X; Wang H; Zhang L; Zhao Y; Zhang Y
    Drug Des Devel Ther; 2015; 9():6275-83. PubMed ID: 26664049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal Effects of Sulodexide in Type 2 Diabetic Patients without Nephrotic Range Proteinuria.
    Yongwatana K; Supasyndh O; Satirapoj B
    J Diabetes Res; 2020; 2020():2984680. PubMed ID: 32851094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparanase in Kidney Disease.
    van der Vlag J; Buijsers B
    Adv Exp Med Biol; 2020; 1221():647-667. PubMed ID: 32274730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.